Cargando…
Cardiovascular Disease Biomarkers and suPAR in Predicting Decline in Renal Function: A Prospective Cohort Study
INTRODUCTION: Soluble urokinase-type plasminogen activator receptor (suPAR) strongly predicts outcomes and incident chronic kidney disease (CKD) in patients with cardiovascular disease (CVD). Whether the association between suPAR and CKD is a reflection of its overall association with chronic inflam...
Autores principales: | Hayek, Salim S., Ko, Yi-An, Awad, Mosaab, Ahmed, Hina, Gray, Brandon, Hosny, Kareem Mohammed, Aida, Hiroshi, Tracy, Melissa J., Wei, Changli, Sever, Sanja, Reiser, Jochen, Quyyumi, Arshed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678674/ https://www.ncbi.nlm.nih.gov/pubmed/29142970 http://dx.doi.org/10.1016/j.ekir.2017.02.001 |
Ejemplares similares
-
Assay-related differences in SuPAR levels: implications for measurement and data interpretation
por: Vasbinder, Alexi, et al.
Publicado: (2022) -
suPAR: An Inflammatory Mediator for Kidneys
por: Sudhini, Yashwanth Reddy, et al.
Publicado: (2022) -
suPAR, a Circulating Kidney Disease Factor
por: Wei, Changli, et al.
Publicado: (2021) -
SuPAR mediates viral response proteinuria by rapidly changing podocyte function
por: Wei, Changli, et al.
Publicado: (2023) -
Reassessing the Reassessment of suPAR in Glomerular Disease
por: Meijers, Björn K. I., et al.
Publicado: (2015)